Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Patients and data tracking

EcoVadis silver badge

Cuttsy+Cuttsy’s first EcoVadis rating comes back silver!

Louise Jones, Sustainability Officer at Cuttsy+Cuttsy celebrates their new silver sustainability rating

Cuttsy + Cuttsy

- PMLiVE

Nucleus Global are winners of ‘Medical Affairs Agency of the Year’ at Communiqué 2022

Triple success across Inizio at the leading European Healthcare Communications Awards

Nucleus Global

- PMLiVE

AbbVie submits migraine prevention drug to EMA for marketing authorisation

If approved, atogepant would be the first daily oral CGRP receptor antagonist migraine treatment for adults in Europe

- PMLiVE

Roche’s diagnostic test for Alzheimer’s receives FDA Breakthrough Device Designation

Alzheimer's affects more than 55 million people globally and is the most common form of dementia

- PMLiVE

NICE recommends Rhythm Pharmaceuticals’ Imcivree for severe obesity and hyperphagia

The treatment will be funded and available for use within 90 days in the NHS

- PMLiVE

VMLY&R Health welcomes Jo Crouch and Khalid Latif to senior executive team in London

Crouch is appointed as managing director and Latif takes on the role of executive creative director

- PMLiVE

Onyx Health Expands with Two New Digital Appointments

Onyx Health has expanded its digital content team with the appointments of Hope Johnston as Digital Content Manager and Jordan Carr as Social Media Executive.

Onyx Health

- PMLiVE

GSK’s consumer health spin-off Haleon starts trading with £31bn market valuation

The company finalised its demerger of the Consumer Healthcare business group to form the new organisation

- PMLiVE

Merck KGaA announces launch of start-up collaboration programme in Asia

The selected companies will receive up to €100,000 in financial assistance, as well as mentoring from Merck

- PMLiVE

The White House reveals its ‘Cancer Cabinet’ line-up as its Moonshot initiative progresses

The panel includes its new chairperson, Elizabeth Jaffee, Mitchel Berger and Carol Brown

Time to improve healthcare outcomes

We live in an era of robust and thorough evidence and there is no place for historical biases and that requires everyone involved to look beyond women’s reproductive cycle and...

Page & Page Health

- PMLiVE

Bristol Myers Squibb announces NICE recommendation for Opdivo plus Yervoy to treat unresectable malignant pleural mesothelioma

The treatment combination is the first immunotherapy of its kind in over ten years to be made available via the NHS

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links